BioSpace News Archive

Today, Health Canada authorized a second bivalent COVID-19 vaccine booster.

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a drug discovery company aimed at developing therapeutics that regenerate muscle as a new approach to treating disease conditions from muscular dystrophy to aging, announced today that its board of directors (the “Board”) has approved grants of stock options (the “Stock Options”) pursuant to the terms of the Company’s Stock Option Plan.

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that the Company granted non-statutory stock options to a new employee as inducement awards outside of the Company’s 2019 Stock Incentive Plan.

RadioMedix, Inc., a clinical-stage biotechnology company announced an agreement with an entity related to Portland Investment Counsel Inc. involving an equity investment of $40 million Series A funding round.

BioSig Technologies, Inc. an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, announced that San Antonio Methodist Hospital has acquired the PURE EP™ System.

Pfizer Canada ULC and BioNTech SE today announced that Health Canada has authorized COMIRNATY Original & Omicron BA.4/BA.5 as a 30-μg booster dose for individuals ages 12 years and older.

Global manufacturer and distributor of high-quality airway and respiratory products, Pulmodyne, Inc., and fluidics-based MedTech company, fluidIQ, Inc., announced today a global licensing and joint research and development agreement.

TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Acceletronics, headquartered in Exton, PA, and sister company RadParts, headquartered in Haslett, MI.

Apellis Pharmaceuticals, Inc. announced that the company approved the grant of equity awards to 8 new employees with a grant date of October 3, 2022, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.

LimaCorporate proudly announces the FDA approval of a new shoulder platform focused on versatility and Operating Room efficiency.